FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1973239372> ?p ?o ?g. }

• W1973239372 endingPage "634" @default.
• W1973239372 startingPage "628" @default.
• W1973239372 abstract "Chemotherapy with aggressive focal ablative therapy is now the mainstay of retinoblastoma therapy. Our experience presents an evolution from conventional radiotherapy by treating posterior pole tumours with focal stereotactic fractionated radiotherapy (SRT).A retrospective chart review was conducted of five patients (six eyes) treated with SRT at the Hospital for Sick Children and Princess Margaret Hospital, Toronto, Canada, between 1999 and 2004. The prescribed dose was 40 Gy delivered in 20 fractions once daily using 6 MV photons.Five patients (six eyes) were treated. The median age at the time of SRT was 18 months. The median follow-up was 46.5 months as of September 2004. Four patients were treated for a posterior pole focal tumour by focal SRT, and one patient was treated for vitreous seeding with whole-eye SRT. In patients treated with focal SRT, the median doses to the tumour, optic chiasm and brainstem were 41.92, 0.25 and 0.07 Gy, respectively, and to the ipsilateral optic nerve, globe and lens were 9.98, 19.11 and 3.74 Gy, respectively. The median doses to the ipsilateral and contralateral orbital bone were 6.73 Gy (range 5.99-8.29 Gy) and 2.31 Gy (range 0.88-7.08 Gy), respectively. A complete response (residual inactive scar tissue) was seen in four of the five focal tumours treated, with one tumour responding with a partial response (suspicious residual scar tissue). No acute or late side-effects occurred in patients treated with focal SRT. Only the patient treated with whole-eye SRT developed late effects of cataract and corneal ulceration. One patient suffered recurrence within the radiation field 5 months after focal SRT. Control of this recurrence was successful using chemotherapy and focal therapy. No eye has been enucleated.Vision-sparing focal SRT for localised tumour masses in critical locations can control tumours with minimal side-effects and a minimal dose to the surrounding critical normal tissue." @default.
• W1973239372 created "2016-06-24" @default.
• W1973239372 creator A5010438214 @default.
• W1973239372 creator A5015138770 @default.
• W1973239372 creator A5025628194 @default.
• W1973239372 creator A5027813699 @default.
• W1973239372 creator A5051051033 @default.
• W1973239372 creator A5069616282 @default.
• W1973239372 creator A5080440840 @default.
• W1973239372 creator A5088281221 @default.
• W1973239372 date "2006-10-01" @default.
• W1973239372 modified "2023-10-10" @default.
• W1973239372 title "Focal Stereotactic External Beam Radiotherapy as a Vision-sparing Method for the Treatment of Peripapillary and Perimacular Retinoblastoma: Preliminary Results" @default.
• W1973239372 cites W1983322464 @default.
• W1973239372 cites W1984659269 @default.
• W1973239372 cites W1988966440 @default.
• W1973239372 cites W1991249729 @default.
• W1973239372 cites W1994837276 @default.
• W1973239372 cites W1996362416 @default.
• W1973239372 cites W2007518330 @default.
• W1973239372 cites W2009553091 @default.
• W1973239372 cites W2012796815 @default.
• W1973239372 cites W2013735685 @default.
• W1973239372 cites W2016070168 @default.
• W1973239372 cites W2033621332 @default.
• W1973239372 cites W2045388751 @default.
• W1973239372 cites W2050459506 @default.
• W1973239372 cites W2051404433 @default.
• W1973239372 cites W2055250290 @default.
• W1973239372 cites W2057857623 @default.
• W1973239372 cites W2057990213 @default.
• W1973239372 cites W2074538055 @default.
• W1973239372 cites W2085345998 @default.
• W1973239372 cites W2097512974 @default.
• W1973239372 cites W2102706108 @default.
• W1973239372 cites W2105363094 @default.
• W1973239372 cites W2108808305 @default.
• W1973239372 cites W2123528350 @default.
• W1973239372 cites W2125238636 @default.
• W1973239372 cites W2126034416 @default.
• W1973239372 cites W2134294240 @default.
• W1973239372 cites W2136154953 @default.
• W1973239372 cites W2162201423 @default.
• W1973239372 cites W2172926263 @default.
• W1973239372 cites W2178526654 @default.
• W1973239372 doi "https://doi.org/10.1016/j.clon.2006.06.013" @default.
• W1973239372 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17051954" @default.
• W1973239372 hasPublicationYear "2006" @default.
• W1973239372 type Work @default.
• W1973239372 sameAs 1973239372 @default.
• W1973239372 citedByCount "20" @default.
• W1973239372 countsByYear W19732393722012 @default.
• W1973239372 countsByYear W19732393722015 @default.
• W1973239372 countsByYear W19732393722016 @default.
• W1973239372 countsByYear W19732393722017 @default.
• W1973239372 countsByYear W19732393722019 @default.
• W1973239372 countsByYear W19732393722022 @default.
• W1973239372 crossrefType "journal-article" @default.
• W1973239372 hasAuthorship W1973239372A5010438214 @default.
• W1973239372 hasAuthorship W1973239372A5015138770 @default.
• W1973239372 hasAuthorship W1973239372A5025628194 @default.
• W1973239372 hasAuthorship W1973239372A5027813699 @default.
• W1973239372 hasAuthorship W1973239372A5051051033 @default.
• W1973239372 hasAuthorship W1973239372A5069616282 @default.
• W1973239372 hasAuthorship W1973239372A5080440840 @default.
• W1973239372 hasAuthorship W1973239372A5088281221 @default.
• W1973239372 hasConcept C104317684 @default.
• W1973239372 hasConcept C118487528 @default.
• W1973239372 hasConcept C141071460 @default.
• W1973239372 hasConcept C185592680 @default.
• W1973239372 hasConcept C2775908122 @default.
• W1973239372 hasConcept C2776577112 @default.
• W1973239372 hasConcept C2777416452 @default.
• W1973239372 hasConcept C2778257484 @default.
• W1973239372 hasConcept C2779797997 @default.
• W1973239372 hasConcept C2780387249 @default.
• W1973239372 hasConcept C2780837183 @default.
• W1973239372 hasConcept C2989005 @default.
• W1973239372 hasConcept C2992393070 @default.
• W1973239372 hasConcept C509974204 @default.
• W1973239372 hasConcept C55493867 @default.
• W1973239372 hasConcept C65691976 @default.
• W1973239372 hasConcept C71924100 @default.
• W1973239372 hasConceptScore W1973239372C104317684 @default.
• W1973239372 hasConceptScore W1973239372C118487528 @default.
• W1973239372 hasConceptScore W1973239372C141071460 @default.
• W1973239372 hasConceptScore W1973239372C185592680 @default.
• W1973239372 hasConceptScore W1973239372C2775908122 @default.
• W1973239372 hasConceptScore W1973239372C2776577112 @default.
• W1973239372 hasConceptScore W1973239372C2777416452 @default.
• W1973239372 hasConceptScore W1973239372C2778257484 @default.
• W1973239372 hasConceptScore W1973239372C2779797997 @default.
• W1973239372 hasConceptScore W1973239372C2780387249 @default.
• W1973239372 hasConceptScore W1973239372C2780837183 @default.
• W1973239372 hasConceptScore W1973239372C2989005 @default.
• W1973239372 hasConceptScore W1973239372C2992393070 @default.
• W1973239372 hasConceptScore W1973239372C509974204 @default.
• W1973239372 hasConceptScore W1973239372C55493867 @default.

• next